Back to results
US 2010/0249423 A1Published application
Tolperisone controlled release tablet
AssigneeSanochemia Pharmazeutika AG
InventorsStefan Welzig, Jan Rothenburger, Beate Kälz, József Gungl, Klaus Gerdes
Life of this patent
Estimating the term…
Abstract
A GRDDS (Gastro Retentive Drug Delivery System) containing tolperisone and having a 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) fraction of less than 1.5 ppm for the extended release of the active substance tolperisone while avoiding the formation of 4-MMPPO in the gastrointestinal tract.
Claims1
A GRDDS (Gastro Retentive Drug Delivery System) containing tolperisone and having a 4-MMPPO fraction of less than 1.5 ppm for the extended release of the active substance tolperisone while avoiding the formation of 4-MMPPO in the gastrointestinal tract.
Dependencies are inferred from the claim text.